NCT06917079 2026-03-18
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Phase 1 Recruiting
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Verastem, Inc.
Pfizer
Revolution Medicines, Inc.
Eli Lilly and Company
Shanghai Junshi Bioscience Co., Ltd.